Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBLeActivated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

Garcia, LMG; Escudero, A; Mestre, C; Soler, JLF; Martinez, AP; Valero, JMV; Vela, M; Ruz, B; Navarro, A; Fernandez, L; Fernandez, A; Leivas, A; Martinez-Lopez, J; Ferreras, C; De Paz, R; Blanquer, M; Galan, V; Gonzalez, B; Corral, D; Sisinni, L; Mirones, I; Balas, A; Vicario, JL; Valle, P; Borobia, AM; Perez-Martinez, A – 2021